Key Takeaways Expert panel developed guidelines for onabotulinumtoxinA use in OAB, emphasizing patient experience and compliance. Recommendations cover patient counseling, pre-procedure urinalysis, ...

Panelists discuss how leveraging resources such as patient assistance programs, insurance navigators, clinical trial databases, advocacy groups, and oncology support services can help overcome access ...

Key Takeaways Mitomycin for intravesical solution is the first FDA-approved treatment for recurrent LG-IR-NMIBC, with availability expected by July 2025. The phase 3 ENVISION trial demonstrated a 78% ...

The Novel Tracer 89Zr-TLX250 Main Discussion Topics: 89Zr-TLX250 is an antibody that binds to carbonic anhydrase IX (CAIX). CAIX is an enzyme expressed on the surface of most clear cell renal cell ...

Key Takeaways Technological advancements in sacral neuromodulation include MRI-conditional devices, rechargeable systems, and extended battery lifespans, enhancing patient eligibility and reducing ...

The ZIRCON Trial and Molecular Imaging Main Discussion Topics: The ZIRCON trial evaluated a novel PET tracer (89Zr-TLX250) for characterizing small renal masses. The trial demonstrated high ...

There has been an explosion of treatment options in non–muscle invasive bladder cancer (NMIBC) in recent years, with even more coming down the pike. Many of these agents have demonstrated encouraging ...

Lymph Node Management and Molecular Imaging Main Discussion Topics: The current approach typically limits lymph node dissection to radiographically evident disease. Molecular imaging could identify ...

Currently, several FDA-approved agents treat BCG-unresponsive carcinoma in situ (CIS), with or without papillary disease. Pembrolizumab, a single-agent checkpoint inhibitor, has a complete response ...

Clinical Decision-Making for Abiraterone Formulations This segment explores the practical considerations urologists face when selecting appropriate abiraterone formulations for individual patients ...

Key Takeaways Cabozantinib, with or without atezolizumab, demonstrates efficacy in advanced RCC patients post first-line immunotherapy combinations. Progression-free survival and overall survival are ...

Food-Drug Interactions and Absorption Considerations This segment provides crucial information about the significant impact of food on abiraterone absorption and the clinical implications for patient ...